[Monitoring of patients using atypical psychotics and screening for metabolic syndrome]
- PMID: 20162964
[Monitoring of patients using atypical psychotics and screening for metabolic syndrome]
Similar articles
-
Challenges in advancing mental and physical health of patients with serious mental illness.J Psychopharmacol. 2005 Nov;19(6 Suppl):3-5. doi: 10.1177/0269881105058969. J Psychopharmacol. 2005. PMID: 16280332 No abstract available.
-
Biological perspectives. Metabolic syndrome: schizophrenia and atypical antipsychotics.Perspect Psychiatr Care. 2006 Aug;42(3):204-7. doi: 10.1111/j.1744-6163.2006.00073.x. Perspect Psychiatr Care. 2006. PMID: 16916424 Review. No abstract available.
-
Metabolic and lifestyle issues and severe mental illness--new connections to well-being?J Psychopharmacol. 2005 Nov;19(6 Suppl):188-22. J Psychopharmacol. 2005. PMID: 19886294 No abstract available.
-
Medical risk in patients with bipolar disorder and schizophrenia.J Clin Psychiatry. 2006;67 Suppl 9:25-30; discussion 36-42. J Clin Psychiatry. 2006. PMID: 16965186 Review.
-
[Increased risk of cardiovascular diseases and diabetes in mentally ill persons. Life style is a contributing factor].Lakartidningen. 2003 Jul 10;100(28-29):2353-5. Lakartidningen. 2003. PMID: 12899026 Swedish. No abstract available.